In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action (Q46631898)
Jump to navigation
Jump to search
scientific article published on 24 January 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action |
scientific article published on 24 January 2006 |
Statements
1 reference
In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action (English)
1 reference
Cliff Battram
1 reference
Bernard Cuenoud
1 reference
Mark R Dowling
1 reference
Robin A Fairhurst
1 reference
David Farr
1 reference
John R Fozard
1 reference
Juliet R Leighton-Davies
1 reference
Christine A Lewis
1 reference
Lorraine McEvoy
1 reference
Robert J Turner
1 reference
Alexandre Trifilieff
1 reference
24 January 2006
1 reference
317
1 reference
2
1 reference
762-770
1 reference